“We’re witnessing a renaissance in cytokine targeting,” says Dr. Emily Rhodes, immunologist at the Stanford Institute for Translational Medicine. “And TNF-α is still the most contested—and the most ...
Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global health issue. MAFLD is closely linked to ...